1. Home
  2. USAS vs INBX Comparison

USAS vs INBX Comparison

Compare USAS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.31

Market Cap

1.5B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$84.10

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
INBX
Founded
1998
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2004
2024

Fundamental Metrics

Financial Performance
Metric
USAS
INBX
Price
$4.31
$84.10
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$6.50
$150.00
AVG Volume (30 Days)
3.7M
249.2K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
$174.68
N/A
Revenue Next Year
$53.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
550.00
52 Week Low
$0.87
$20.55
52 Week High
$10.50
$155.29

Technical Indicators

Market Signals
Indicator
USAS
INBX
Relative Strength Index (RSI) N/A 44.34
Support Level N/A $69.57
Resistance Level N/A $85.97
Average True Range (ATR) 0.00 4.45
MACD 0.00 0.04
Stochastic Oscillator 0.00 49.91

Price Performance

Historical Comparison
USAS
INBX

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: